Stay Informed on Corporate Sustainability

Author: Pharmaceutical Technology

Pfizer has secured a $530m (€445m) vaccine licensing deal with US-based Novavax, centred on its proprietary Matrix-M adjuvant. The agreement underscores corporate partnerships and vaccine innovation in the US life sciences sector.

Author: Euractiv

Ireland has finalised two framework agreements with pharmaceutical manufacturers to accelerate access to new medicines and strengthen supply chains. The deals set reimbursement timelines and aim to enhance Ireland’s competitiveness in the global life sciences sector.

Author: Jed Nykolle Harme

The pharma and life sciences sector continues to evolve through a careful balance of innovation, regulation and human capital, with confidence shaped by long-term thinking rather than short-term gains. This edition brings together perspectives that reflect how leadership, capability and skills development reinforces the sector’s resilience. Credited for redefining standards over the past year, ‘Celtic Biotech wins Biotech Company of the Year at Pharma Industry Awards 2025’ stands as a marker of excellence achieved through scientific focus and organisational discipline. That recognition sets a strong reference point as expectations build towards the 2026 awards, where sustained impact and strategic clarity will remain under close scrutiny. Alongside this, ‘Build Scalable Scientific Teams with SGS Insourcing’ highlights how flexible workforce models are becoming integral to operational confidence, reflecting a broader shift towards adaptability as a competitive advantage in complex regulatory environments. Meanwhile, ‘BioPharmaChem Skillnet Launches Foundational Programme for Aspiring Pharmaceutical Manufacturing Professionals’ underscores the importance of structured learning pathways in securing future capability. Talent development is increasingly viewed as a strategic investment rather than a supporting function. These stories offer readers a lens on how excellence, people and preparation are shaping the next chapter of pharma and life sciences.

Author: Jed Nykolle Harme

Celebrated for its forward-thinking strategies last year, Celtic Biotech was named Biotech Company of the Year at the Pharma Industry Awards 2025, setting a benchmark for innovation in peptide therapies and patient-focused research as attention turns to the 2026 awards cycle.

Author: thepharmaletter

Spanish pharmaceutical company Esteve has agreed to acquire a US-based specialty therapies unit to expand its pharma and life sciences footprint in the United States. The deal strengthens its specialty medicines portfolio and commercial presence.

Author: businesswire

US-based CDMO Agno Pharma acquires an Oregon API manufacturing site to expand its pharmaceutical development and GMP production capabilities. The deal strengthens its life sciences manufacturing footprint and supports growing demand from biotech and pharma clients.

Author: siliconrepublic

Uniphar acquires Irish pharmacy software provider TouchStore and invests in a state-of-the-art Dublin distribution facility. The moves aim to expand wholesale capacity and enhance technology solutions for community pharmacies across Ireland.

Author: Jed Nykolle Harme

SGS Pharma Ireland helps life sciences companies accelerate drug development and maintain regulatory compliance with its Scientific Insourcing solutions to boost operational performance and project delivery.

Author: Jed Nykolle Harme

BioPharmaChem Skillnet and Innopharma Education open applications for the QQI Level 5 Essentials for Pharmaceutical Manufacturing programme, offering skills and qualifications for careers in bio-pharma and chemical processing.

Author: Jed Nykolle Harme

The pharma and life sciences sector is advancing with greater clarity as performance, responsibility and people-led strategy converge. This edition reflects an editorial approach designed to surface insight that supports long-term thinking across an increasingly complex industry. Looking back at a benchmark year, 'Arriello Ireland wins Pharma Contract Services Company of the Year at Pharma Industry Awards 2025' marked a moment where delivery excellence and service maturity were firmly recognised. That achievement helps frame expectations as attention turns towards the 2026 awards and the standards they will continue to reinforce. Alongside this, 'SGS ISL Achieves My Green Lab Platinum Certification' highlights the growing role of sustainability in shaping operational credibility. The certification reflects how environmental responsibility is becoming embedded in quality, compliance and corporate trust. Lastly, a broader perspective on progress emerges in the sector through 'Neurodiversity in the Workplace: Leading the Way with the World’s First University-Accredited Programme.' Together, these stories point to a sector strengthening its foundations through excellence, accountability and inclusive leadership, encouraging readers to explore how pharma continues to evolve with purpose.